Eikon TherapeuticsEIKN
那斯達克 · USD
6.72
-0.54
(-7.44%)
收盤 10/14 03:59 (UTC+8)
10/14 03:59 (UTC+8)
Eikon TherapeuticsEIKN
6.72
-0.54
(-7.44%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2024/Q4 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - |
營業費用 | 93,394 | 87,337 | 83,168 | 74,751 | 109,643 | 67,777 | 265,737 |
研發費用 | 75,460 | 70,047 | 65,229 | 59,313 | 69,189 | 53,860 | 207,261 |
推銷及管理費用 | 17,934 | 17,290 | 17,939 | 15,438 | 40,454 | 13,917 | 58,476 |
非經常性項目費用 | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - |
營業利益 | -93,394 | -87,337 | -83,168 | -74,751 | -109,643 | -67,777 | -265,737 |
其他收入及費用 | -52 | -1 | 3,465 | - | - | - | 23,779 |
利息費用 | - | - | -48 | - | - | 7 | 39 |
稅前純益 | -88,409 | -82,958 | -79,655 | -71,139 | -105,211 | -64,924 | -241,997 |
所得稅 | - | - | - | - | - | - | - |
稅後純益 | -88,409 | -82,958 | -79,655 | -71,139 | -105,211 | -64,924 | -241,997 |
基本每股稅後盈餘(元) | -1.63 | -2.46 | - | - | -1.95 | - | - |
稀釋每股稅後盈餘(元) | -1.44 | -2.46 | -26.23 | - | -1.95 | - | - |
基本平均股數(千股) | 54143.00 | 33700.00 | - | - | 53984.00 | - | - |
稀釋平均股數(千股) | 54143.00 | 33700.00 | - | - | 53984.00 | - | - |
還原基本每股稅後盈餘(元) | -1.63 | -2.46 | - | - | -1.95 | - | - |
還原稀釋每股稅後盈餘(元) | -1.44 | -2.46 | -26.23 | - | -1.95 | - | - |
還原基本平均股數(千股) | 54,143 | 33,700 | - | - | 53,984 | - | - |
還原稀釋平均股數(千股) | 54,143 | 33,700 | - | - | 53,984 | - | - |
EBITDA(千元) | -83,740 | -78,672 | -75,463 | -64,842 | -98,903 | -58,702 | -245,323 |